BUY Anthem Biosciences — Sachin Janardan Sarvade, 12 Aug 2026

bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: Swing (≤2wk)12 Aug 2026via NDTV Profit

Entry₹800Stated

Target₹990

Stop lossNot given

Exit—No position was opened

ExpiredNA

Follow Sachin Janardan Sarvade for new calls(18% target hit, 50 closed calls)Get alerts Watch ANTHEM for new buy/sell callsGet alerts See 4 active Swing calls on ANTHEM See 264 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 25 Aug 2026

9 supporting1 neutral0 opposing

Supports the BUY call (9)

Jefferies initiates coverage on Anthem Biosciences with a Rs 1,050 target

NewsEt-Markets·21 Aug · 4d ago

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·17 Aug · 1w ago

Anthem Biosciences Share Price: லாபம் **₹591 கோடி** உயர்வு! பங்கு **2%** ஏற்றம்!

NewsGoogle News·3 Aug · 3w ago

Anthem Biosciences Shares Gain 2% After Profit Rises to ₹591 Crore

NewsGoogle News·3 Aug · 3w ago

Anthem Biosciences शेअरमध्ये तेजी! FY26 मध्ये नफा ₹591 कोटींवर

NewsGoogle News·3 Aug · 3w ago

Neutral / worth noting (1)

Anthem Biosciences Share: दमदार FY26 नतीजे, पर Q1 FY27 में आई नरमी, निवेशक इन बातों पर रख रहे नज़र

NewsGoogle News·10 Aug · 2w ago

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Anthem Biosciences Limited — Sachin Janardan Sarvade, IDBI Capital Markets and Securities

AI Assessment